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Aims: To investigate the 17-β estradiol in the acetylcholinesterase activity and lipid peroxidation in the brain
and blood of ovariectomized rats of different ages.
Main methods: Animals were randomly assigned into three experimental groups of each age (n=6). Control
groups consisted of adult (sham-A) and middle-aged (sham-MA) female rats, ovariectomized adult (OVX-A)
and middle-aged (OVX-MA) rats without estrogen therapy reposition, and ovariectomized adult (OVX+E2-
A) and middle-aged (OVX+E2-MA) rats treated with 17-β estradiol for 30 days. After this period, AChE ac-
tivity and lipid peroxidation were measured in the brain and blood.
Key ﬁndings: The AChE activity increased (pb0.05) in striatum (ST) in OVX-A, OVX+E2-A and OVX-MA,
and hippocampus (HP) in OVX-MA. The enzyme activity decreased (pb0.05) in ST of OVX+E2-MA, and
cerebral cortex (CC) in OVX+E2-A, OVX-MA and OVX+E2-MA. Blood AChE activity increased (pb0.05)
in OVX+E2-A and decreased (pb0.05) in OVX-MA. Lymphocyte AChE activity increased (pb0.05) in
OVX-A and OVX+E2-A and decreased (pb0.05) in OVX-MA. Lipid peroxidation increased (pb0.05) in
ST of OVX-A, CC of OVX-A and OVX-MA, HP of OVX-A, and cerebellum (CE) of OVX-A, OVX-MA, and
OVX+E2-MA. Lipid peroxidation decreased (pb0.05) in ST, CC and CE of OVX+E2-A, and ST and HP of
OVX+E2-MA. Similar values of lipid peroxidation to control groups were found in ST and HP of OVX-
MA, HP of OVX+E2-A and CC of OVX+E2-MA.
Signiﬁcance: 17-β estradiol is able to modulate the AChE activity and non-neuronal cholinergic response as
well as to reduce lipid peroxidation. Its response is dependent on the age and brain structure analyzed.© 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
The aging of the normal brain is accompanied by changes in its
structure, function, and metabolism (Moorthy et al., 2005; Thakur
and Sharma, 2006). Most of these changes are regulated by the estro-
gen which is derived from either circulation or steroidogenesis in the
brain (McEwen and Alves, 1999). Post-menopausal women are more
vulnerable than young women to neurodegenerative diseases, result-
ing in memory and cognitive dysfunction (Wise et al., 2001). Howev-
er, the risk for dementia is increased in young women who did
bilateral oophorectomy as well as in women who discontinued estro-
gen therapy before 50 years of age. In this context, the ovarianiversitário, Centro de Ciências
ima, 97105-900, Santa Maria,
978.
. Lopes).
vier OA license.hormone 17-β estradiol has shown a protective effect in many neuro-
degenerative conditions. It decreases the risk and delays the onset
and progression of Alzheimer's disease (AD) (García-Segura et al.,
2001; Vegeto et al., 2008). Moreover, it enhances the recovery from
traumatic neurological injury such as cerebral ischemia (Cimarosti
et al., 2005).
Different ages and ovariectomy produce a progressive damaging
effect on the nervous and immune functions (Baeza et al., 2010). Re-
cent investigations have suggested that estrogens exert a protective
effect against brain disorders from the evidence that menopause,
which is characterized by the drastic drop in estrogen levels, results
in an increased incidence of inﬂammatory pathologies of brain
(Pozzi et al., 2006). However, ovariectomy in younger women (prior
to menopause) signiﬁcantly increases the risk for the development
of memory problems and neurodegenerative disorders. However,
the biological basis underlying these cognitive changes is still poorly
understood (Craig et al., 2010). The onset-age of estrogen deﬁciency
352 D.B. Martins et al. / Life Sciences 90 (2012) 351–359appears to be an important determinant of long term health (Rocca
et al., 2009). Thus, some of the mechanisms underlying these effects
may be independent of the classically deﬁned estrogen receptors
(ER) and may involve direct modulation of neurotransmitter receptor
function or anti-oxidant activities of estrogen (García-Segura et al.,
2001; Li and Shen, 2005).
Beneﬁcial effects of estrogens on brain aging and cognition are re-
lated to interactions with cholinergic projections emanating from the
basal forebrain. These cholinergic projections play an important role
in the learning andmemory processes as well as in neuronal plasticity
and cognitive performance. Moreover, their function is known to de-
cline with advanced age and in association with neurodegenerative
diseases (Gibbs, 2010). Cholinergic neurons are signiﬁcantly affected
by changes in circulating levels of estrogen (Gibbs and Aggarwal,
1998) suggesting that the effectiveness of estrogen therapy decreases
with age (Gibbs, 2010).
Acetylcholinesterase enzyme (AChE; E.C. 3.1.1.7), found in the
cholinergic terminal, is a speciﬁc choline esterase, which hydrolyzes
predominantly choline esters (acetylcholine — ACh) and is character-
ized by being present in high levels in the brain, nerve and red blood
cells (Das, 2007). Until recently, neurons were the only identiﬁed
source of ACh. It is now known that cells, other than neurons, express
the proteins required for ACh metabolism. ACh is synthesized,
amongst others, by immune system (lymphocytes, dendritic cells,
neutrophils) and endothelial cells (Kawashima and Fujii, 2000). It is
possible that ACh derived from these sources be involved in the mod-
ulation of local inﬂammatory processes and regulation of immune
functions (Das, 2007).
Cholinergic signaling in non-neuronal cells is comparable to cho-
linergic neurotransmission (Wessler et al., 2003). In this aspect, cell
activation is a key modulator of the non-neuronal cholinergic system.
It is likely that a lymphocytic cholinergic system is involved in regu-
lating immune function (Razani-Boroujerdi et al., 2008). Changes in
lymphocyte AChE activity, therefore, reﬂect immune deﬁciency relat-
ed to cell dysfunction (Battisti et al., 2009).
The 17-β estradiol is able to inﬂuence the development, regula-
tion, and functioning of the immune system (Baeza et al., 2010).
This hormone can inﬂuence many aspects of the central nervous sys-
tem (CNS) and immune function. Moreover, understanding the cellu-
lar and molecular mechanisms that underlie these protective actions
is essential to prevent the deleterious consequences of prolonged
hypoestrogenicity and to improve women's health (Wise et al.,
2001). The mechanism of neuroprotection remains still to be under-
stood (Cimarosti et al., 2005; Sales et al., 2010). However, it is still de-
bated whether estrogen treatment could result in improved cognitive
function and other aspects in women after the menopause
(Hogervorst and Bandelow, 2010).
Estrogen replacement has also been reported as beneﬁcial against
several biological reactions in the body, such as maintenance or in-
crease in the antioxidant capacity and decreased levels of oxidative
stress (Aguiar et al., 2008), especially during menopause (Moorthy
et al., 2005). Also, the lack of estrogen can induce changes in lipid me-
tabolism, with an increase of oxidative status (Signorelli et al., 2006)
and fat accumulation in the body resulting in weight gain (Mittal and
Kant, 2009).
Although hormonal replacement therapy may be one of the great-
est conquests in the battle for quality of life for women, many factors
should be considered regarding its use (Aguiar et al., 2006). Estrogen
replacement therapy has showed a reduction in risk factors related to
aging, oxidative stress (Moorthy et al., 2005; Aguiar et al., 2006,
2008), and neurological disorders (Wise et al., 2001; Pozzi et al.,
2006; Vegeto et al., 2008). Thus, we hypothesized that 17-β estradiol
replacement could improve parameters related to the AChE activity in
the brain, total blood and lymphocytes, as well as lipid peroxidation
in the brain and weight gain in adult and middle-aged ovariecto-
mized female rats.Materials and methods
Chemicals
The hormone 17-β estradiol, substrate, and buffers were obtained
from Sigma Chemical Co (St. Louis, MO, USA). All the other reagents
used in the experiments were of analytical grade and of the highest
purity.Animals
Thirty six female Wistar rats were used. Eighteen animals were
5 months old (adults) and the other 18 were 10 months old (middle-
aged). The rats were maintained at a constant temperature (21±2 °C)
on a 12 h light/dark cycle with free access to food and water. The
study was performed in accordance with the Federal University of
SantaMaria Ethics Committee Guidelines for Experimentswith Animals
(process 86/2009). A soy-free rat chow (Supra®, Alisul, Carazinho, RS,
Brazil) was used to avoid phytoestrogen interference.
After a week of habituation, the animals were submitted to vaginal
smear for 2 weeks to verify the normal estrous cycle (Marcondes
et al., 2002; Yener et al., 2007). Just rats with normal cycle entered
in the experiment. The animals were weighted and, then, immediate-
ly submitted to the ovariectomy (OVX) procedures.Surgical procedure
We chose the OVX to mimic the estrogen deprivation in animals
since this is a model commonly used for this purpose (Monteiro
et al., 2005; Acosta et al., 2009). The animals were anesthetized ini-
tially with 4% halothane in a 40% O2/60% N2O mixture and the anes-
thesia was maintained during the bilateral OVX with 1.5–2.5%
halothane breathing spontaneously via facemask. Control groups
underwent a sham surgery with an incision in the Alba line, but with-
out gonad removal. After a recovery period of 15 days, all animals
were submitted again to vaginal smear to conﬁrm the efﬁcacy of the
surgical procedures (4 days) and then the treatment started.Experimental groups and treatments
Adult andmiddle-aged rats were randomly assigned into three ex-
perimental groups of each age (n=6), where control groups con-
sisted of adult (sham-A) and middle-aged (sham-MA) female rats in
proestrus, ovariectomized adult (OVX-A) and middle-aged (OVX-
MA) rats without estrogen therapy reposition, and ovariectomized
adult (OVX+E2-A) and middle-aged (OVX+E2-MA) rats treated
with 17-β estradiol. Sham and OVX groups received just canola oil ve-
hicle, while OVX+E2 groups received 0.1 μg/g of body weight of 17-β
estradiol (according to Moorthy et al., 2005).
We started the hormonal reposition 15 days after OVX, time need-
ed to bring down estrogen levels and absence of estrous cycle by vag-
inal cytology. Intervals of months between the OVX and the
beginning of the hormonal treatment should be avoided because es-
trogen replacement therapy has no action when started after a
long-term hormone deprivation (Daniel et al., 2006). Moreover, our
choice for the oral administration of estrogens is because that is a
practical and widely used method by women (Aguiar et al., 2008).
Canola oil vehicle and 17-β estradiol were administered with the
same volume, by oral gavage, once a day. The administration was con-
tinuous for 30 days, and in the following day (euthanasia day) there
was no treatment. On day 30, the animals were weighted again to
compare the weight of the rats in the beginning and in the end of
the experimental period.
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We used the enzymatic method of automated immuno-
chemiluminescence with Immulite 2000 analyzer (Diagnostic Products
Corporation, Los Angeles, CA, USA) and speciﬁc hormone kit (Immulite
Estradiol).Brain tissue preparation
The animals were submitted to euthanasia being previously anes-
thetized with halothane and brain structures were immediately re-
moved, separated into striatum (ST), hippocampus (HP), cerebral
cortex (CC) and cerebellum (CE), placed in a solution of 10 mM
Tris–HCl, pH 7.4, on ice at a proportion of 1:10 (w/v) and after ho-
mogenized. The homogenate was centrifuged at 1800 rpm for
10 min and the resulting supernatant (S1) was stored at −30 °C
until use. Protein was determined previously in a strip that varied
for each structure: ST (0.4 mg/mL), HP (0.8 mg/mL), CC (0.7 mg/
mL), and CE (0.6 mg/mL) as determined by the Coomassie blue meth-
od according to Bradford (1976) using bovine serum albumin as stan-
dard solution.Cerebral AChE enzymatic assay
The AChE enzymatic assay was determined by a modiﬁcation of
the spectrophotometric method of Ellman et al. (1961) as previously
described by Rocha et al. (1993). The reactionmixture (2 mL ﬁnal vol-
ume) was composed of 100 mM K+-phosphate buffer, pH 7.5 and
1 mM 5,50-dithiobisnitrobenzoic acid (DTNB). The method is based
on the formation of yellow anion, 5,50-dithio-bis-acidnitrobenzoic,
measured by absorbance at 412 nm during 2-min incubation at
25 °C. The enzyme (40–50 mg of protein) was pre-incubated for
2 min. The reaction was initiated by adding 0.8 mM acetylthiocholine
iodide (AcSCh). All samples were run in duplicate or in triplicate, and
the enzyme activity was expressed in μmoles AcSCh/h/mg of protein.17-  estradiol
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Fig. 1. Serum 17-β estradiol levels evaluated by immuno-chemiluminescence of femaleIsolation of the cells
The peripheral lymphocytes were isolated using Ficoll Hypaque
density gradient as described by Böyum (1968). After separation,
only samples with at least 95% of lymphocytes, as veriﬁed in the coul-
ter STKS (Miami—USA), were used. Lymphocyte viability and integri-
ty were conﬁrmed by determining the percentage of cells, excluding
0.1% trypan blue and measuring lactate dehydrogenase (LDH) activity
(Bergmeyer, 1983).adult and middle-aged rats. Sham-A (adult female rat in proestrus), OVX-A (adult fe-
male ovariectomized rat without estrogen therapy reposition) and OVX+E2-A (adult
female ovariectomized rat treated with 0.1 μg/g of 17-β estradiol) are distributed in
the white columns. Sham-MA (middle-aged female rat in proestrus), OVX-MA
(middle-aged female ovariectomized rat without estrogen therapy reposition) and
OVX+E2-MA (middle-aged female ovariectomized rat treated with 0.1 μg/g of 17-β
estradiol) are distributed in the gray columns. Bars represent mean±SEM.*Denotes
pb0.05 when compared with adult control group (Sham-A) (one-way analysis of var-
iance/Duncan's multiple range test, n=6). #Denotes pb0.05 when compared with the
middle-aged control group (Sham-A) (one-way analysis of variance/Duncan's multiple
range test, n=6).Determination of AChE activity in whole blood
The AChE enzymatic assay was determined by the method of
Ellman et al. (1961) modiﬁed by Worek et al. (1999). The speciﬁc ac-
tivity of whole blood AChE was calculated from the quotient between
AChE activity and hemoglobin content and the results are expressed
as mU/μmol of whole blood.Determination of AChE activity in lymphocytes
After the isolation of the lymphocytes, AChE activitywas determined
according to themethod described by Ellman et al. (1961) andmodiﬁed
by Fitzgerald and Costa (1993). Brieﬂy, proteins of all samples were ad-
justed to 0.1–0.2 mg/ml. 0.2 ml of intact cells was added to a solution
containing 1.0 mM acetylthiocholine (ATC), 0.1 mM 5,5′-dithiobis(2-
nitrobenzoic acid) (DTNB), and 0.1 M phosphate buffer (pH 8.0). Imme-
diately before and after incubation for 30 min, at 27 °C, the absorbance
was read on a spectrophotometer at 412 nm. AChE was calculated
from the quotient between lymphocyte AChE activity and protein con-
tent, and the results were expressed as μmol/h/mg of protein.
Thiobarbituric acid reactive substances (TBARS) measurement
Brain TBARS levels were determined by themethod described previ-
ously by Ohkawa et al. (1979). In short, the reaction mixture contained
200 μL of brain homogenates or standard (MDA—malondialdehyde
0.03 mM), 200 μL of 8.1% sodium dodecyl sulfate (SDS), 500 μL of acetic
acid solution (2.5 M HCl, pH 3.5) and 500 μL of 0.8% thiobarbituric acid
(TBA). The absorbance was measured at 532 nm. TBARS tissue levels
were expressed as nmol MDA/mg of protein.
Statistical analysis
The statistical analysis used was one-way ANOVA, followed by
Duncan's multiple range tests. All the data are expressed as the
mean±standard error. Differences were considered signiﬁcant
when the probability was pb0.05.
Results
Adult and middle-aged control animals showed a normal estrous cy-
clic activity throughout the experimental period (cycle duration: 4 to
5 days), being in proestrus on the day of euthanasia. Ovariectomized
rats without estrogen treatment presented continuous diestrus cytology
conﬁrming the reduction of circulating hormone. Ovariectomized rats
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Fig. 3. Acetylcholinesterase (AChE) activity in the total blood of female adult andmiddle-
aged rats. Sham-A (adult female rat in proestrus), OVX-A (adult female ovariectomized
rat without estrogen therapy reposition) and OVX+E2-A (adult female ovariectomized
rat treated with 0.1 μg/g of 17-β estradiol) are distributed in the white columns. Sham-
MA (middle-aged female rat in proestrus), OVX-MA (middle-aged female ovariecto-
mized rat without estrogen therapy reposition) and OVX+E2-MA (middle-aged female
ovariectomized rat treatedwith 0.1 μg/g of 17-β estradiol) are distributed in the gray col-
umns. Bars representmean±SEM. *Denotes pb0.05when comparedwith the adult con-
trol group (Sham-A) (one-way analysis of variance/Duncan'smultiple range test, n=6).
#Denotes pb0.05 when compared with the middle-aged control group (Sham-A) (one-
way analysis of variance/Duncan's multiple range test, n=6).
354 D.B. Martins et al. / Life Sciences 90 (2012) 351–359with 17-β estradiol supplementation showed daily typical proestrus
cells. Estradiol levels were measured in all groups (Fig. 1) and revealed
a signiﬁcant difference (pb0.05) on the hormonal reduction of both
ovariectomized age groups (OVX-A and OVX-MA) when compared to
the control and supplemented groups of the same age. The estrogen re-
position groups (OVX+E2-A and OVX+E2-MA) showed similar physi-
ological values to those exhibited on proestrus by the control group.
AChE activity was evaluated in the supernatant (S1) in all cerebral
structures (CC, ST, HP and CE) (Fig. 2). In the ST, the ovariectomy signif-
icantly increased (pb0.05) the activity of the enzyme for OVX-A and for
OVX-MA. However, AChE behavior varied according to hormonal repo-
sition. While the adult group OVX+E2-A showed a signiﬁcant increase
in the AChE activity (pb0.05) in the middle-aged group OVX+E2-MA
demonstrated a signiﬁcant decrease (pb0.05) in the enzyme activity. In
relation to the CC in thematerial S1, in the adult group, the ovariectomy
(OVX-A) did not modify AChE activity, but with the hormonal replace-
ment (OVX+E2-A) there was a signiﬁcant decrease (pb0.05) in the
activity of the enzyme. In the middle-aged animals, a signiﬁcant de-
crease (pb0.05) occurred in both ovariectomized group (OVX-MA)
and in the group with estrogenic reposition (OVX+E2-MA). In the
HP, there was no signiﬁcant alteration among the adult groups. Howev-
er, in the middle-aged animals, the ovariectomy induced a signiﬁcant
increase (pb0.05) in the activity of AChE in the OVX-MA group. In
the CE of adult andmiddle-aged animals, there was no signiﬁcant alter-
ation in the activity of AChE among the groups of both ages.
The AChE activity in total blood (Fig. 3) of the adult animals
showed no signiﬁcant alteration when compared to sham-A groupCerebral Cortex
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Fig. 2. Acetylcholinesterase (AChE) activity in different structures (striatum, cerebral cortex, hippocampus, and cerebellum) of the brain of female adult and middle-aged rats.
Sham-A (adult female rat in proestrus), OVX-A (adult female ovariectomized rat without estrogen therapy reposition) and OVX+E2-A (adult female ovariectomized rat treated
with 0.1 μg/g of 17-β estradiol) are distributed in the white columns. Sham-MA (middle-aged female rat in proestrus), OVX-MA (middle-aged female ovariectomized rat without
estrogen therapy reposition) and OVX+E2-MA (middle-aged female ovariectomized rat treated with 0.1 μg/g of 17-β estradiol) are distributed in the gray columns. Bars represent
mean±SEM.⁎,⁎⁎Denote pb0.05 when compared with the adult control group (Sham-A) (one-way analysis of variance/Duncan's multiple range test, n=6). #,##Denote pb0.05
when compared with the middle-aged control group (Sham-A) (one-way analysis of variance/Duncan's multiple range test, n=6).
355D.B. Martins et al. / Life Sciences 90 (2012) 351–359to OVX-A group. In spite of that, the supplementation with 17-β es-
tradiol induced a signiﬁcantly increased (pb0.05) in the OVX-E2-A.
In the middle-aged animals, the ovariectomized group (OVX-MA)
had a signiﬁcant decrease (pb0.05) in the activity of the enzyme.
But interestingly, at this same age, the group treated with estrogen
(OVX+E2-MA) showed no signiﬁcant alteration when compared to
sham-MA and OVX-MA.
Lymphocyte AChE activity (Fig. 4) was signiﬁcantly increased
(pb0.05) in OVX-A and OVX+E2-A of adult animals. In the middle-
aged animals, there was a decrease (pb0.05) in lymphocyte AChE ac-
tivity inﬂuenced by the ovariectomy in the OVX-MA group. However,
the supplementation with 17-β estradiol, as seen in the OVX+E2-MA
group, had a signiﬁcant increase (pb0.05) when compared to the
control group (sham-MA).
TBARS production in the ST, CC, HP and CE of the adult and
middle-aged animals is shown in Fig. 5. In the ST, the ovariectomy in-
creased signiﬁcantly (pb0.05) the TBARS production only in the adult
castrated animals (OVX-A), while in the middle-aged castrated ani-
mals (OVX-MA) the values were similar to those showed by the
middle-aged control group (sham-MA). However, both age groups
treated with 17-β estradiol (OVX+E2-A and OVX+E2-MA) showed
a signiﬁcant decrease (pb0.05) of the TBARS production, indicating a
reduction in the lipid peroxidation. TBARS production of CC had a sig-
niﬁcant increase (pb0.05) in both ovariectomized groups (OVX-A
and OVX-MA) when compared to their control age groups (sham-A
and sham-MA, respectively). The adult group supplemented with
17-β estradiol (OVX+E2-A) demonstrated a signiﬁcant reduction
(pb0.05) of the TBARS production, while in the middle-aged group
supplemented with 17-β estradiol (OVX+E2-MA) the group showed
TBARS values similar to those presented by the sham-MA group. In
the HP, OVX-A showed a signiﬁcant increase (pb0.05) of the lipid
peroxidation, while OVX-MA presented similar values to sham-MA.
The adult group OVX+E2-A demonstrated similar TBARS production
to sham-A, and the middle-aged group OVX+E2-MA showed a sig-
niﬁcant decrease (pb0.05) in TBARS production. In the CE, there
was a signiﬁcant increase (pb0.05) in the TBARS production in the
ovariectomized groups of both ages (OVX-A and OVX-MA) and inAChE - Lymphocytes
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Fig. 4. Acetylcholinesterase (AChE) activity in the lymphocytes of female adult and
middle-aged rats. Sham-A (adult female rat in proestrus), OVX-A (adult female ovari-
ectomized rat without estrogen therapy reposition) and OVX+E2-A (adult female
ovariectomized rat treated with 0.1 μg/g of 17-β estradiol) are distributed in the
white columns. Sham-MA (middle-aged female rat in proestrus), OVX-MA (middle-
aged female ovariectomized rat without estrogen therapy reposition) and OVX+E2-
MA (middle-aged female ovariectomized rat treated with 0.1 μg/g of 17-β estradiol)
are distributed in the gray columns. Bars represent mean±SEM. *Denotes pb0.05
when compared with the adult control group (Sham-A) (one-way analysis of vari-
ance/Duncan's multiple range test, n=6). #Denotes pb0.05 when compared with the
middle-aged control group (Sham-A) (one-way analysis of variance/Duncan's multiple
range test, n=6).the middle-aged group treated with 17-β estradiol (OVX+E2-MA).
On the other hand, OVX+E2-A showed a signiﬁcant decrease
(pb0.05) of TBARS production.
Post hoc comparisons by Duncan's multiple range test revealed
that the weight of the adult animals was higher in OVX-A group
(pb0.05) and OVX+E2-A (pb0.01) when compared to sham-A
control group (Table 1). On the other hand, the weight of the
middle-aged animals was higher just in OVX-MA group (pb0.05)
when compared to sham-MA control group, while there was no sig-
niﬁcant alteration between OVX+E2-MA and sham-MA (Table 2).
Discussion
In the present study we veriﬁed the effect of 17-β estradiol on the
AChE activity of brain (ST, CC, HP, and CE), blood, and lymphocyte, as
well as lipid peroxidation and weight gain of ovariectomized adult
and middle-aged female rats. We have chosen ovariectomy because
this model is considered the best tool to mimic human ovarian hor-
mone loss, being able to cause a premature aging of the nervous
and immune system (Baeza et al., 2010). 17-β estradiol is considered
to be the major ovarian hormone and its deﬁcits may be related to the
modulatory role on cholinergic innervations in brain, especially in
areas associated to the memory processes such as hippocampus
(McEwen, 2001; Craig et al., 2010). Furthermore, AChE is likely to
play an important role in regulating immune functions, since this en-
zyme is present in blood and lymphocytes (Kawashima and Fujii,
2000; Kawashima and Fujii, 2003). There is scarce information on
the AChE activity of cholinergic system related to the non-
cholinergic system in the estrogenic reposition in females of different
ages. Moreover, we seek to understand whether some of the changes
observed in the activity of this enzyme in our study could be attribut-
ed to lipid peroxidation, an index of oxidative stress.
About 2% of the striatal neurons are cholinergic (Zhou et al.,
2002). Our ST results showed that the activation of the enzyme in
this area occurs in both ovariectomized groups (OVX-A and OVX-
MA) and in the adult group with hormone replacement (OVX+
E2-A). AChE activation leads to a fast ACh degradation and the sub-
sequent downstimulation of ACh receptors (Grisaru et al., 1999). In
this study, the ST was the only brain structure in the adult animals
that demonstrated elevation of the activity of AChE. In adult ani-
mals, estrogen replacement (OVX+E2-A) has further heightened
the activity of AChE compared with the ovariectomized group
(OVX-A). The high concentration of AChE or an increase of enzymat-
ic activity as seen in this case, in the ST, could rapidly terminate the
ACh signal, and thereby minimize desensitization of nAChR (Zhou
et al., 2002). Additionally to this process, the absence of estrogen
can reduce in 50% ChAT production (Tam et al., 2002). ACh is also
considered a neurotransmitter with anti-inﬂammatory effect (Das,
2007), and its low availability could facilitate damaging processes
in this part of the brain. However, the estrogenic effect on AChE
caused an inhibition of this enzyme activity in middle-aged animals
(OVX+E2-MA), showing that in the ST, adult and middle-aged an-
imals may have distinct AChE activity although having the same
treatment. ER-α or ER-β subtypes have not been found extensively
in the striatum (Shughrue et al., 1997) and a decrease of ER-β
may occur with aging (Chakraborty et al. 2003). Thus, despite ST
has its cholinergic system altered by the estrogenic depletion in a
similar way in both adult and middle-aged animals, 17-β estradiol
supplementation may cause an increase or a decrease in the AChE
activity according to the age analyzed.
Our ﬁndings in the CC, one of the areas commonly affected in
several neurodegenerative diseases (Kasa et al., 1997), showed
that despite OVX in adult rats has no inﬂuence in the AChE activity,
the OVX in the middle-aged animals and estrogenic supplementa-
tion in both ages can cause an inhibition of the AChE activity. Unlike
the present study, Monteiro et al. (2005) studying the effect of OVX
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Fig. 5. Thiobarbituric acid reactive substances (TBARS) measurement in different structures (striatum, cerebral cortex, hippocampus, and cerebellum) of the brain of female adult
and middle-aged rats. Sham-A (adult female rat in proestrus), OVX-A (adult female ovariectomized rat without estrogen therapy reposition) and OVX+E2-A (adult female ovari-
ectomized rat treated with 0.1 μg/g of 17-β estradiol) are distributed in the white columns. Sham-MA (middle-aged female rat in proestrus), OVX-MA (middle-aged female ovari-
ectomized rat without estrogen therapy reposition) and OVX+E2-MA (middle-aged female ovariectomized rat treated with 0.1 μg/g of 17-β estradiol) are distributed in the gray
columns. Bars represent mean ± SEM. ⁎,⁎⁎Denote pb0.05 when compared with the adult control group (Sham-A) (one-way analysis of variance/Duncan's multiple range test,
n=6). #,##Denote pb0.05 when compared with the middle-aged control group (Sham-A) (one-way analysis of variance/Duncan's multiple range test, n=6).
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while Acosta et al. (2009), who studied 12 month-old female rats,
found no signiﬁcant AChE changes in this area due to ovarian hor-
mone loss. An inhibition of this enzyme may have many conse-
quences on the brain, as AChE is involved in many neuronal
events (Mesulam et al., 2002).
In relation to HP, a brain area associated with memory and cog-
nition, adult animals showed no difference between treatments.
Feng et al. (2004) also observed no changes in the activity of this
enzyme after 17 weeks of OVX, or even after the replacement for
16 weeks with 17-β estradiol in this brain region. Thus, the lack of
ovarian hormones as well as exogenous estrogen replacement doesTable 1
Average weights and standard deviation of female adult sham rats (Sham-A), female
ovariectomized adult rats without hormone therapy reposition (OVX-A) and female
ovariectomized adult rats supplemented with 0.1 μg/g of 17-β estradiol (OVX+E2-A).
Groups Average weight (g) and
standard deviation
Sham-A 0.232±0.009
OVX-A 0.304⁎±0.01
OVX+E2-A 0.271⁎±0.012
Bars represent mean±SD. Duncan's multiple range test, (n=6).
⁎ Indicates a signiﬁcant difference at pb0.05.not seem to inﬂuence the behavior of AChE in adult female rats.
However, other studies found an increase of the enzyme activity in
younger ovariectomized animals (Monteiro et al., 2005). However,
the HP of the OVX-MA animals showed a stimulation of AChE activ-
ity, which agrees with the results reported by Acosta et al. (2009).
In this aspect, there is an important impairment in the ACh concen-
tration, which is a neurotransmitter that regulates the levels and ac-
tivities of serotonin, dopamine, and other neuropeptides involved in
many neurodegenerative diseases; thus, ACh modulates both im-
mune response and neurotransmission (Das, 2007). We suggest
that the decrease in the estrogenic levels in middle-aged rats mayTable 2
Average weights and standard deviation of female middle-aged sham rats (Sham-MA),
female ovariectomized middle-aged rats without hormone therapy reposition (OVX-
MA) and female ovariectomized middle-aged rats supplemented with 0.1 μg/g of 17-
β estradiol (OVX+E2-MA).
Groups Average weight (g) and
standard deviation
Sham-MA 0.301±0.01
OVX-MA 0.334#±0.007
OVX+E2-MA 0.309±0.02
Bars represent mean±SD. Duncan's multiple range test, (n=6).
# Indicates a signiﬁcant difference at pb0.05.
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the other hand, the middle-aged ovariectomized animals that re-
ceived 17-β estradiol (OVX+E2-MA) were able to normalize the ac-
tivity of AChE. Thus, estrogen has a neuroprotective role in the HP in
this age group, since its presence resulted in AChE activity similar to
the control group. The inhibited AChE activity to values similar to
the control group could contribute to learning and memory by the
possible increasing of ACh level (Das et al., 2005).
The estrogenic hormone can improve learning skills by potentiat-
ing cerebellar plasticity and synapse formation, especially in periods
of high estradiol levels of the estrous cycle (Andreescu et al., 2007).
In our study, the CE was the only brain structure that remained
unchanged in all groups studied. There was no inﬂuence of the OVX
or estrogen replacement on the activity of AChE in adult, as well as
in middle-aged female rats. However, Moorthy et al. (2005) observed
that AChE activity in CE can decay in 12 month-old naturally meno-
pausal rats and this alteration could be associated to several factors
such as concentration of the circulating ovarian hormones, number
of receptors, and afﬁnity for the steroid. Thus, age and OVX may be
important factors to inﬂuence the AChE activity in this brain area,
since our animals were ovariectomized and were 5 and 10 months
old. In addition, CE is a structure with few cholinergic pathways
(Zimmerman and Soreq, 2006) that can explain its low AChE activity
in relation to the other structures studied.
The duration and/or the critical period of initiation of estrogen
therapy should be considered important for an inﬂuence on the
brain AChE activity (Pereira et al., 2008). Another important aspect
is that HP and CC, which receive cholinergic projections from the nu-
cleus basalis of Meynert and ST (which has an intrinsic cholinergic cir-
cuit), did not present similar results in our research. Heterogeneous
localization of estrogen receptors in the brainmay be a possible reason
for the varied inﬂuence of OVX and estrogen treatment on the AChE
activity in different brain areas (Das et al., 2001). Although adult HP
and CE of the different ages studied were not inﬂuenced by our treat-
ments, OVX impaired AChE activity in adult ST andmiddle-aged ST, HP
and CC. However, 17-β estradiol was not able to revert AChE activity in
adult ST and middle-age CC, it decreased the enzyme activity in adult
CC and middle-aged ST, and ﬁnally it normalized the AChE activity in
middle-aged HP. Thus, estrogen has age- and brain region-speciﬁc se-
lective beneﬁcial effects on cholinergic system (Browne et al., 2009).
ACh has an important participation in several neurodegenerative
diseases, particularly in those that affect cognition. Measuring the
AChE activity can provide evidence, at least indirectly, of how the
concentration of ACh is in the brain (Das, 2007). Thus, the evaluation
of the non-neuronal cholinergic system is a relevant parameter that
should be related to different ages, menopausal status, estrogenic
therapy, as well as brain cholinergic system.
An important aspect of the present study is related to the evalua-
tion of the non-neuronal AChE activity in the blood and lymphocytes
that showed distinct behavior among the groups. Our results in the
AChE activity of whole blood and lymphocytes of adult animals indi-
cate a high activity of this enzyme, reﬂecting an activation of the cho-
linergic immune system in this age. The AChE activity in lymphocytes
of adult animals remained high regardless of whether or not they re-
ceived estrogen supplementation (OVX-A and OVX+E2-A). In whole
blood, OVX did not affect AChE activity, but the estrogenic reposition
increased its activity. Our results may indicate that an increased AChE
activity could hydrolyze ACh more quickly, thereby reducing its anti-
inﬂammatory effects due to the absence of negative feedback control
exerted by this neurotransmitter. Additionally, ACh binds to nAChR in
lymphocyte surfaces and inhibits the proliferation of many inﬂamma-
tory substances, such as cytokines and reactive oxygen species (ROS)
(Kawashima and Fujii, 2003; Das, 2007; Rao et al., 2007). For this,
AChE could be used as a marker of low-grade systemic inﬂammation,
since its activity can be elevated in initial stages of some neuronal dis-
orders, such as AD (Das, 2007).On the other hand, there was a low activity of AChE in whole
blood and in lymphocytes of the middle-aged ovariectomized animals
without estrogen replacement (OVX-MA). A decrease in AChE activ-
ity can also affect the normal function of the immune system
(Battisti et al., 2009), demonstrating that the absence of ovarian
hormones in females of older age can be injurious in this aspect.
Our ﬁndings show the impairment that the estrogen reduction can
cause in the non-neuronal cholinergic system of the middle-aged
animals. Interestingly, Das (2007) and Rao et al. (2007) reported
that a lower activity of the enzyme can occur in patients with termi-
nal stages of AD or diabetes mellitus, which may indicate a serious
risk of death.
Thus, we suspect that age is a key component in the relationship of
non-neuronal cholinergic system and estrogen replacement therapy.
It is possible that the reduced activity of this enzyme in middle-
aged animals could be as a result of exhaustion of its stores associated
or not with low synthesis (Das, 2007), whereas in adult animals the
enzyme activity is still high. However, our ﬁndings indicate a better
action of the estrogenic reposition in the extra cholinergic immune
response of the middle-aged animals when compared to the adult
ones. It was possible to observe that the supplementation with 17-β
estradiol (OVX+E2-MA) was able to normalize lymphocyte AChE ac-
tivity from animals of this age group. Regarding the fraction of whole
blood, we observed that the administration of 17-β estradiol normal-
ized just partially AChE activity, since its value was statically similar
to the control group but also to the ovariectomized animals. Thus,
AChE is an important therapeutic target and its pattern may differ
on the basis of age (Das et al., 2001), as we observed in lymphocytes
and whole blood of adult and middle-aged female rats.
It is known that decreased levels of estrogen may contribute to
possible damage to the CNS (Schumacher et al., 2003). In this aspect,
estrogens may also protect brain attenuating the formation of free
radicals (Wise et al., 2001; Aguiar et al., 2008). Interestingly, AChE ac-
tivity responds to various insults including oxidative stress, an impor-
tant event that has been related to the pathogenesis and progression
of a variety of CNS disorders (Mattson and Pedersen, 1998; Chauhan
and Chauhan, 2006), OVX (Monteiro et al., 2005) and age (Moorthy
et al., 2005; Aguiar et al., 2008). Thus, we also investigated the lipid
peroxidation in order to explain a possible mechanism that contrib-
utes to the AChE activity alteration in our study.
The generation of ROS, which may happen with aging (Aguiar
et al., 2008), and OVX (Ha et al. 2006) induce cellular membrane
damage. AChE is an enzyme that contributes to the maintenance of
cell membrane integrity and possible changes in permeability may
occur during synaptic transmission and conduction (Das et al.,
2001). Among the globular forms of this enzyme, G1 is cytosolic and
G4 is membrane bound; G4 is also the most abundant form in several
brain regions (Das et al., 2001; Aldunate et al., 2004; Das et al., 2005).
Hormonal inﬂuences, such as replacement or estrogen depletion, on
the cell membrane from adult or middle-aged animals could interfere
in an oxidative process, leading to a change in conformation of AChE,
thus, modifying its activity.
In our study, when comparing the results obtained with adult and
middle-aged animals, we can suppose that age may interfere in the
production of free radicals that cause lipid peroxidation in OVX or es-
trogenic hormone reposition. The intense action of lipid peroxidation
in the adult ovariectomized animals (OVX-A) observed in the four
brain structures studied reﬂects the susceptibility and vulnerability
of the CNS of females of this age with a decline in ovarian hormone
levels. Interestingly, the effect of 17-β estradiol supplementation
was able to reduce lipid peroxidation values in most brain structures
or even match it to normal levels, as in the case of HP. This fact can be
explained because the HP of adult animals have a rich lipid content
and high metabolic activity, which is more characteristic of younger
ages than those of middle-aged (Aguiar et al., 2008). In adult animals,
despite estrogen supplementation has been beneﬁcial both in HP and
358 D.B. Martins et al. / Life Sciences 90 (2012) 351–359in other brain structures analyzed in our study, the 17-β estradiol
acted more intensively at CC, ST, and CE.
Contrary to what happened in adult ovariectomized animals, the
advanced age in HP and ST of the middle-aged OVX-MA may have re-
duced the lipid content and the metabolic activity of these structures
(Aguiar et al. 2008), preventing the increase in lipid peroxidation in
this condition. The different responses obtained in the four brain
structures examined in middle-aged animals undergoing estrogen
therapy (OVX+E2-MA) may be due to a variation in the concentra-
tion of antioxidant compounds in different brain regions. CE is an ex-
ample that shows the lowest concentration of antioxidants
(Vatassery 1992). Unlike what happened in adult animals, in the
middle-aged animals the estrogen supplementation in the CE failed
to reverse the action of lipid peroxidation.
It has been reported an increased local oxidative stress in fat accu-
mulation in the body (Gower et al. 1998). These ﬁndings are impor-
tant when adult and middle-aged ovariectomized animals without
hormone reposition (OVX-A and OVX-MA) are analyzed. In this
point, weight gain was more intense in the adult group compared to
the middle-aged group. Despite that estrogen therapy have reversed
lipid peroxidation in all brain structures of adult animals, this hor-
mone failed to match the weight of the supplemented group (OVX
+E2-A) to the control group. We can suggest that the use of 17-β es-
tradiol was beneﬁcial for the middle-aged animals where the average
weight was equal to the control group. The fact that weight gain in
OVX-MA was not so intense when compared to adult animals may
have favored the action of the estrogen therapy in this age group. In
this aspect, our study reveals that the lack of circulating estrogen
may induce weight gain as well as increase lipid peroxidation espe-
cially in the adult animals. This is relevant, since oxidative stress in-
creases when an increase in weight gain is observed (Mittal and
Kant 2009).
In conclusion, the present results show that 17-β estradiol re-
placement is able to modulate the AChE activity and reduce lipid per-
oxidation and its response is dependent of age and brain structure
analyzed. We also showed that OVX impaired more intensively the
non-cholinergic system of middle-aged animals but estrogenic repo-
sition can reverse this condition on this age. Furthermore, this study
suggests that this hormone may inﬂuence the local immune response,
enhancing the action of estrogen. Estrogen supplementation also nor-
malizes body weight in middle-aged ovariectomized rats. These data
provide new perspectives to estrogen treatment in the neurodiseases
in women, since this hormone effects vary according to the age and
different parts of the brain.
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